Skip to main content

ADVERTISEMENT

Aaron Gerds, MD

Aaron Gerds, MD
Videos
02/02/2024
Aaron Gerds, MD, examines potential treatment risks for patients with myelofibrosis and how to mitigate them in order to achieve the best possible outcomes.
Aaron Gerds, MD, examines potential treatment risks for patients with myelofibrosis and how to mitigate them in order to achieve the best possible outcomes.
Aaron Gerds, MD, examines...
02/02/2024
Oncology
Aaron Gerds, MD
Videos
02/02/2024
Aaron Gerds, MD, discusses the phase 3 MOMENTUM trial on momelotinib treatment for patients with myelofibrosis, including those with anemia, which served as the basis for the approval of momelotinib by the US FDA.
Aaron Gerds, MD, discusses the phase 3 MOMENTUM trial on momelotinib treatment for patients with myelofibrosis, including those with anemia, which served as the basis for the approval of momelotinib by the US FDA.
Aaron Gerds, MD, discusses the...
02/02/2024
Oncology